neurodegenerative diseases
Study Pinpoints Potential “Master Regulator” of Age-Related Cognitive Decline
Study Pinpoints Potential “Master Regulator” of Age-Related Cognitive Decline
Shawna Williams | Dec 18, 2017
Upping a gene’s expression in rat brains made them better learners and normalized the activity of hundreds of other genes to resemble the brains of younger animals.
Prions Found in Skin of Creutzfeldt-Jakob Patients
Prions Found in Skin of Creutzfeldt-Jakob Patients
Jef Akst | Nov 24, 2017
Infectious protein aggregates from the skin of human patients can cause disease in mice.
Research Links Gut Health to Neurodegeneration
Research Links Gut Health to Neurodegeneration
Jef Akst | Nov 13, 2017
Rodent studies presented at the Society for Neuroscience meeting this week tie pathologies in the gastrointestinal tract or microbiome composition with Parkinson’s and Alzheimer’s diseases.
How Microbes May Influence Our Behavior
How Microbes May Influence Our Behavior
Amy Lewis | Sep 1, 2017
Researchers are piecing together the links between the gut microbiome and mental health.
Do Microbes Trigger Alzheimer’s Disease?
Do Microbes Trigger Alzheimer’s Disease?
Jill U. Adams | Sep 1, 2017
The once fringe idea is gaining traction among the scientific community.
Infographic: Brain Infection and Alzheimer’s Disease Pathology
Infographic: Brain Infection and Alzheimer’s Disease Pathology
Jill U. Adams | Aug 31, 2017
Emerging evidence links bacterial or viral infection with the neuropathology of Alzheimer’s disease.
Parkinson’s Disease Cell Therapy Relieves Symptoms in Monkeys
Parkinson’s Disease Cell Therapy Relieves Symptoms in Monkeys
Abby Olena | Aug 30, 2017
Neurons derived from human induced pluripotent stem cells fill in for lost dopamine neurons in a primate model of the disease.
A Potential Remedy for the Aging Brain
A Potential Remedy for the Aging Brain
Aggie Mika | Aug 8, 2017
In mice, injected fragments of a naturally occurring protein boost memory in young and old animals and improve cognition and mobility in a model of neurodegenerative disease. 
Second-Ever ALS Drug Approved
Second-Ever ALS Drug Approved
Jef Akst | May 8, 2017
Amyotrophic lateral sclerosis patients in the U.S. now have an option besides riluzole, which was approved by the FDA more than two decades ago and only extends life by two or three months.
Opinion: Canine Models for Alzheimer’s
Opinion: Canine Models for Alzheimer’s
Edward G. Barrett | Mar 1, 2017
For research on drugs to treat neurodegenerative diseases, dogs offer a better predictor of clinical outcomes.